BioPharma Pharma QC

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

 January 26, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

 January 23, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

 January 23, 2023 | News

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC

  World's first anti-PD-1 mAb for the first-line treatment of SCLC Making a new record with the median OS of 15.8 months in an international, mult...

 January 18, 2023 | News

6 Must-Haves for a Quality Management System

Choose the best one for your business by learning about the 6 essentials that an eQMS needs to be effective. If an eQMS doesn't check the...

 January 18, 2023 | News

FDA Accepts GMP Plasmid DMF of OBiO Technology

OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development a...

 January 17, 2023 | News

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Agilent Technologies Inc. (NYSE: A)  announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nuclei...

 January 13, 2023 | News

Research commenced with Keio University to discover drugs using "Chemicals Informatics

 Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commenci...

 January 12, 2023 | News

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

FSD Pharma Inc Announces Three Key Additions to Scientific and Clinical Expert Committee FSD Pharma Inc Announces It Is Investigating Other Products Addre...

 January 10, 2023 | News

Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes

Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) - ...

 January 06, 2023 | News

Polysciences Announces New Bioprocessing Brand, Kyfora Bio

Building on Polysciences’ extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medic...

 January 03, 2023 | News

GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development

According to the collaboration agreements, WuXi XDC will actively promote GeneQuantum’s proprietary iLDC (intelligent Ligase-dependent Conjugation) a...

 December 28, 2022 | News

Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis

Healthy volunteers phase completed showing differentiating target engagement biomarker data and favorable safety data On track for top-line histology da...

 December 19, 2022 | News

Bio Elpida Acquisition Brings GMP Fill and Finish Capacity to Polyplus

“Bio Elpida is certified by the French Health Authorities (ANSM) as a Pharmaceutical Company to manufacture Active Pharmaceutical Ingredients and Adv...

 December 15, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in